Clinical Trial Details


Back to Clinical Trials Database

Phase III study of Tomudex and Cisplatin versus Cisplatin in Malignant Pleural Mesothelioma.

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 26-Nov-1999
Date Step1 close: 06-Jan-2003
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 240
Treatment Cisplatin, Raltitrexed
Study Staff
Type of cancer
Participating groups EORTC Lung Cancer Group
NCIC Clinical Trial Group
Protocol summary
NCT number NCT00004920